![](/img/cover-not-exists.png)
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
Fang, Yu-Hung, Yang, Yao-Hsu, Hsieh, Meng-Jer, Hung, Ming-Szu, Lin, Yu-ChingVolume:
Volume 11
Language:
english
Journal:
Cancer Management and Research
DOI:
10.2147/CMAR.S222278
Date:
September, 2019
File:
PDF, 1.97 MB
english, 2019